Ask AI
Bill114th CongressFiled Jan 12, 2016Health
S. 2443

Advancing Standards in Regenerative Medicine Act

Bill journey · stage 2 of 5

Under committee review

Filed
Comm.
Floor
Both
Law

What it doesSummary introduced in senate (Jan 12, 2016)

Advancing Standards in Regenerative Medicine Act

This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to facilitate the establishment of a public-private Standards Coordinating Body in Regenerative Medicine and Advanced Therapies. The FDA must work with this body to develop standards to support the development and review of regenerative medicine products.

What just happenedJan 12, 2016

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Who’s behind it

Sen. Baldwin, Tammy [D-WI](D-WI)Sponsor
Read on Congress.gov
1committees2actions1related bills6subjects
  1. Jan 12, 2016IntroReferral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Health, Education, Labor, and Pensions Committee
  2. Jan 12, 2016IntroReferral10000

    Introduced in Senate

Advancing Standards in Regenerative Medicine Act — Informed